This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Jan 28;107(3):363-9.

doi: 10.1161/01.cir.0000053730.47739.3c.

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

Paul M Ridker¹

Affiliations

Affiliation

¹ Center for Cardiovascular Disease Prevention and the Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02215, USA. pridker@partners.org

PMID: 12551853
DOI: 10.1161/01.cir.0000053730.47739.3c

Review

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

Paul M Ridker. Circulation. 2003.

. 2003 Jan 28;107(3):363-9.

doi: 10.1161/01.cir.0000053730.47739.3c.

Author

Paul M Ridker¹

Affiliation

¹ Center for Cardiovascular Disease Prevention and the Division of Cardiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02215, USA. pridker@partners.org

PMID: 12551853
DOI: 10.1161/01.cir.0000053730.47739.3c

No abstract available

PubMed Disclaimer

Comment in

Inflammatory markers in coronary heart disease: coronary vascular versus myocardial origin?
Heusch G, Schulz R, Erbel R. Heusch G, et al. Circulation. 2003 Jul 8;108(1):e4; author reply e4. doi: 10.1161/01.CIR.0000079055.99427.3F. Circulation. 2003. PMID: 12847058 No abstract available.

Similar articles

Using C-reactive protein to assess cardiovascular disease risk.
Shishehbor MH, Bhatt DL, Topol EJ. Shishehbor MH, et al. Cleve Clin J Med. 2003 Jul;70(7):634-40. doi: 10.3949/ccjm.70.7.634. Cleve Clin J Med. 2003. PMID: 12882386 Review.
Establishing a clinical basis for hsCRP in the prevention and treatment of cardiovascular disease.
Ridker PM. Ridker PM. Clin Chem. 2010 Jul;56(7):1186-7. doi: 10.1373/clinchem.2009.142240. Epub 2010 Apr 1. Clin Chem. 2010. PMID: 20360125 No abstract available.
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group.
Fortmann SP, Ford E, Criqui MH, Folsom AR, Harris TB, Hong Y, Pearson TA, Siscovick D, Vinicor F, Wilson PF; CDC; AHA. Fortmann SP, et al. Circulation. 2004 Dec 21;110(25):e554-9. doi: 10.1161/01.CIR.0000148982.95775.BF. Circulation. 2004. PMID: 15611381
High-sensitivity C-reactive protein: a useful marker for cardiovascular disease risk prediction and the metabolic syndrome.
Rifai N. Rifai N. Clin Chem. 2005 Mar;51(3):504-5. doi: 10.1373/clinchem.2004.044990. Clin Chem. 2005. PMID: 15738514 No abstract available.
[Role of biomarkers for risk stratification in the prevention of cardiovascular diseases].
Sinning C, Keller T, Blankenberg S. Sinning C, et al. Dtsch Med Wochenschr. 2009 Oct;134(40):2019-22. doi: 10.1055/s-0029-1237551. Epub 2009 Sep 23. Dtsch Med Wochenschr. 2009. PMID: 19777420 Review. German. No abstract available.

See all similar articles

Cited by

No change in interictal C-reactive protein levels in individuals with episodic and chronic migraine: A case-control study and literature review.
Park CG, Lee SH, Chu MK. Park CG, et al. Front Neurol. 2022 Oct 12;13:1021065. doi: 10.3389/fneur.2022.1021065. eCollection 2022. Front Neurol. 2022. PMID: 36313504 Free PMC article.
Favorable Levels of All Major Cardiovascular Risk Factors at Younger Ages and High-Sensitivity C-Reactive Protein 39 Years Later -The Chicago Healthy Aging Study.
Vu TH, Liu K, Lloyd-Jones DM, Stamler J, Pirzada A, Shah SJ, Garside DB, Daviglus ML. Vu TH, et al. Prev Med Rep. 2015;2:235-240. doi: 10.1016/j.pmedr.2015.03.012. Prev Med Rep. 2015. PMID: 25914870 Free PMC article.
Qing-Xin-Jie-Yu Granules in addition to conventional treatment for patients with stable coronary artery disease (QUEST Trial): study protocol for a randomized controlled trial.
Li S, Guo M, Mao H, Gao Z, Xu H, Shi D. Li S, et al. Trials. 2016 Sep 15;17(1):451. doi: 10.1186/s13063-016-1569-9. Trials. 2016. PMID: 27628038 Free PMC article. Clinical Trial.
Relationship of galectin-3 with obesity, IL-6, and CRP in women.
Pang J, Nguyen VT, Rhodes DH, Sullivan ME, Braunschweig C, Fantuzzi G. Pang J, et al. J Endocrinol Invest. 2016 Dec;39(12):1435-1443. doi: 10.1007/s40618-016-0515-8. Epub 2016 Jul 21. J Endocrinol Invest. 2016. PMID: 27444618
HsCRP in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Alavi SA, Soati F, Forghanparast K, Amani H. Alavi SA, et al. Iran Red Crescent Med J. 2011 Oct;13(10):713-8. Epub 2011 Oct 1. Iran Red Crescent Med J. 2011. PMID: 22737409 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
Research Materials
- NCI CPTC Antibody Characterization Program